Ex-Glaxo Official Sues Over Firing Tied to Study Mistakes
- Scientist says he caught flaws in study of Nicoderm products
- Alexandre Selmani said he was fired after alerting CEO
This article is for subscribers only.
A former GlaxoSmithKline Plc executive says he was fired for pointing out flaws in studies used to tout the benefits of the drugmaker’s Nicoderm line of smoking-cessation products.
Alexandre Selmani, hired in 2006 to oversee study designs, claims in a lawsuit that his bosses at a Glaxo unit based in New Jersey ignored his warnings about statistical mistakes in studies of Nicoderm patches and oral inserts. He says he was fired in retaliation for blowing the whistle on the errors.